2024-02-08 13:15:22 ET
Zimmer Biomet Holdings, Inc. (ZBH)
Q4 2023 Earnings Conference Call
February 8, 2024, 8:30 am ET
Company Participants
Keri Mattox - Chief Communications & Administration Officer
Ivan Tornos - President & CEO
Suky Upadhyay - CFO & EVP, Finance, Operations & Supply Chain
Conference Call Participants
Larry Biegelsen - Wells Fargo
Matthew O'Brien - Piper Sandler
Robbie Marcus - J.P. Morgan
Joanne Wuensch - Citi
Ryan Zimmerman - BTIG
Travis Steed - Bank of America
Jeff Johnson - Baird
Richard Newitter - Truist Securities
Jayson Bedford - Raymond James
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet's Fourth Quarter 2023 Earnings Conference Call. [Operator Instructions]. As a reminder, this conference is being recorded today February 8, 2024. Following today's presentation, there will be a question-and-answer session. At this time, all participants are in a listen-only mode. [Operator Instructions].
I would now like to turn the conference over to Keri Mattox, Chief Communications and Administration Officer. Please go ahead.
Keri Mattox
Thank you, operator, and good morning, everyone. Welcome to Zimmer Biomet's fourth quarter 2023 earnings conference call. Joining me today are Ivan Tornos, our President and CEO; and CFO and EVP, Finance, Operations and Supply Chain, Suky Upadhyay.
Before we get started, I'd like to remind you that our comments during this call will include forward-looking statements. Actual results may differ materially from those indicated by the forward-looking statements due to a variety of risks and uncertainties. Please note, we assume no obligation to update these forward-looking statements even if the actual results or future expectations change materially. Please refer to our SEC filings for a detailed discussion of these risks and uncertainties in addition to the inherent limitations of such forward-looking statements.
Additionally, the discussions on this call will include certain non-GAAP financial measures, some of which are forward-looking non-GAAP financial measures. Reconciliation of these measures to the most directly comparable GAAP financial measures and an explanation of our basis for calculating these measures is included within our Q4 earnings release, which can be found on our website, zimmerbiomet.com.
With that, I'll turn the call over to Ivan. Ivan?
Ivan Tornos
Hey, thank you, Keri, and thanks, everyone for joining the call here this morning.
I like to start the way that I typically do, taking a moment to recognize, to show my gratitude to the almost 20,000 Zimmer Biomet team members for their dedication, for their commitment, for their strong resilience, and for their superb performance in 2023. Simply put, 2023 was just a great year for our company and I want to say thank you....
Read the full article on Seeking Alpha
For further details see:
Zimmer Biomet Holdings, Inc. (ZBH) Q4 2023 Earnings Call Transcript